EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Greenhouse Gas Emissions Associated With Severe Asthma Care in the United Kingdom

Alex Wilkinson, Mina Khezrian, Liam G Heaney, Soram Patel, Jennifer K Quint, Hitasha Rupani, Eleni Rapsomaniki, Kirsty Rhodes, Andrew N Menzies-Gow, Trung N Tran

The Journal of Allergy and Clinical Immunology: In Practice · 2025

DOI: 10.1016/j.jaip.2025.02.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2025. Verfasst von Alex Wilkinson und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Stevenage, East and North Hertfordshire NHS Trust, Hertfordshire, United Kingdom. Hauptthemen laut MEDLINE: Asthma, Greenhouse Gases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The 2023 United Nations Climate Change Conference (COP28) Declaration on Climate and Health promotes steps to curb emissions and reduce waste in the health sector. OBJECTIVE: To describe and quantify greenhouse gas (GHG) emissions associated with severe asthma (SA) care in the United Kingdom, by carbon source and transition status from SA to severe uncontrolled asthma (SUA) and/or regular specialist care (RSC). METHODS: This was a cohort study using routinely collected data from the Clinical Practice Research Datalink Aurum, Hospital Episode Statistics, and CO2 equivalent emissions data. Patients were ≥12 years old at the index date (ie, date of first recorded inhaled corticosteroid [ICS] + controller prescription) with a validated asthma diagnosis. Total GHG emissions and GHG emissions related to medications, exacerbations, and health care resource utilization (HCRU) were estimated, overall and by transition along stages of the SA-SUA-RSC continuum. Five pathways and stage orders were identified: (1) SA, (2) SA-SUA, (3) SA-RSC, (4) SA-RSC-SUA, and (5) SA-SUA-RSC. RESULTS: The total CO2 equivalent for the SA population (n = 93,054) was 2167 tonnes/10,000 patients/year. GHG emissions were 5.2% to 23.0% greater for patients transitioned to SUA (vs previous stage), mostly due to exacerbation-related emissions (4.2-7.7 times greater; predominantly hospitalizations) and medication-related emissions (3.5%-10.9% greater; predominantly short-acting β2-agonists [SABAs]). Conversely, total GHG emissions decreased by 12.1% to 23.9% for those referred to RSC, due to decreased exacerbation-related emissions (1.7-5.2 times lower; all sources) and medication-related emissions (14.8%-20.6% lower; both SABA and overall ICS). CONCLUSION: Our findings suggest that RSC not only improves patient outcomes but also reduces GHG emissions in line with aims to reduce the health sector's contribution to the total national carbon footprint.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaGreenhouse GasesHumansUnited KingdomAdultMaleFemaleMiddle AgedAdolescentCohort StudiesYoung AdultAnti-Asthmatic AgentsAgedSeverity of Illness Index

Stichwörter der Autor:innen

Emergency department visitExacerbationHealth care resource utilizationHospitalizationInhaled corticosteroidMedicationOutpatient visitShort-acting β(2)-agonist

Substanzen

Greenhouse GasesAnti-Asthmatic Agents

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Stevenage, East and North Hertfordshire NHS Trust, Hertfordshire, United Kingdom.
  • Biopharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom.
  • Wellcome-Wolfson Institute for Experimental Medicine, Queen's University, Belfast, United Kingdom.
  • School of Public Health, Imperial College London, London, United Kingdom.
  • Department of Respiratory Medicine, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Real World Science, BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom.

Förderung

  • AstraZeneca

Zitieren

APA

Wilkinson, A., Khezrian, M., Heaney, L. G., Patel, S., Quint, J. K., Rupani, H., Rapsomaniki, E., Rhodes, K., Menzies-Gow, A. N., & Tran, T. N. (2025). Greenhouse Gas Emissions Associated With Severe Asthma Care in the United Kingdom. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2025.02.012

Vancouver

Wilkinson A, Khezrian M, Heaney LG, Patel S, Quint JK, Rupani H, et al. Greenhouse Gas Emissions Associated With Severe Asthma Care in the United Kingdom. The Journal of Allergy and Clinical Immunology: In Practice. 2025. doi:10.1016/j.jaip.2025.02.012

BibTeX
@article{Wilkinson2025,
  author = {Wilkinson, Alex and Khezrian, Mina and Heaney, Liam G and Patel, Soram and Quint, Jennifer K and Rupani, Hitasha and Rapsomaniki, Eleni and Rhodes, Kirsty and Menzies-Gow, Andrew N and Tran, Trung N},
  title = {Greenhouse Gas Emissions Associated With Severe Asthma Care in the United Kingdom},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2025},
  doi = {10.1016/j.jaip.2025.02.012}
}
Kostenlos starten →